TrialClinical rheumatology2018

Analysis of relapse rates and risk factors of tapering or stopping pharmacologic therapies in axial spondyloarthritis patients with sustained remission.

Xiaochan Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.